This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Chang Chun Petrochemical Co., Ltd., Chang Chun Plastics Co., Ltd., National Tsing Hua University. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Yu Chen Hu
Introduction: Yu Chen Hu, located in Hsinchu, Taiwan, is a notable inventor recognized for his contributions to the field of genome editing. With a focus on advancing genetic technologies, Hu has made significant strides in developing tools that enhance genomic research and applications.
Latest Patents: Yu Chen Hu holds a patent for a Cas9 expression plasmid, which plays a crucial role in a genome editing system. This innovative invention includes a tracrRNA sequence, a Cas9 gene, and a chloramphenicol resistance gene (Cm). The plasmid is designed for use in a CRISPR/Cas-coupled λ-red recombineering system, enabling high-efficiency genome editing. This advancement promises to facilitate various applications in genetic engineering and biotechnology.
Career Highlights: Throughout his career, Hu has been associated with esteemed institutions, including National Tsing Hua University and Chang Chun Plastics Co., Ltd. His roles at these organizations have provided him with a platform to engage in groundbreaking research and innovation, contributing to the advancement of scientific knowledge.
Collaborations: Yu Chen Hu has collaborated with esteemed colleagues in his field, including Mu-En Chung and I-Hsin Yeh. Collaborative efforts in research and development have been instrumental in fostering creativity and enhancing the impact of their work within the scientific community.
Conclusion: As an inventor, Yu Chen Hu has made significant contributions to the realm of genome editing, particularly through his development of the Cas9 expression plasmid. His work exemplifies the innovative spirit that drives technological advancement in biotechnology. Through collaborations and his experiences at reputable institutions, he continues to push the boundaries of what is possible in genetic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile